|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-30
|
$1,889,710
|
$132,280
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
|
Working Memory Performance among Childhood Brain Tumor Survivors
|
1R21CA131616-01A1
|
$226,800
|
$226,800
|
CONKLIN, HEATHER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Washington University Small Animal Imaging Resource
|
5U24CA083060-10
|
$633,099
|
$31,655
|
ACKERMAN, JOSEPH
|
WASHINGTON UNIVERSITY
|
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-25
|
$453,250
|
$4,533
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
VHL and FGFR signaling in angiogenesis
|
5R01CA109860-05
|
$283,792
|
$93,651
|
HSU, TIEN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
Vascular targeted pan PI-3kinase inhibitor prodrug, SF1126 for glioma therapy.
|
2R56CA094233-06A1
|
$91,969
|
$91,969
|
DURDEN, DONALD
|
EMORY UNIVERSITY
|
|
|
Vaccination With Peptide-loaded alphaDC1s For Malignant Gliomas
|
5R21CA117152-02
|
$282,150
|
$282,150
|
OKADA, HIDEHO
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-35S1
|
$59,955
|
$1,799
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-35
|
$4,795,480
|
$143,865
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UT Southwestern Small Animal Imaging Resource
|
5U24CA126608-02
|
$451,375
|
$90,275
|
MASON, RALPH
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-20
|
$1,758,769
|
$158,290
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Using Zebrafish to Identify and Analyze Cancer Genes
|
5R01CA106416-03
|
$398,901
|
$398,901
|
Lees, Jacqueline
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
|
Using Insights from EGFRvIII to Improve EGFR Directed Therapy in Human Gliomas
|
5R01CA124832-02
|
$300,991
|
$300,991
|
WONG, ALBERT
|
STANFORD UNIVERSITY
|
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
Z01 BC 005673
|
$1,225,024
|
$245,005
|
Keefer, Larry
|
CCR (NCI)
|
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-33S1
|
$74,165
|
$742
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-33
|
$6,658,653
|
$66,587
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-24
|
$1,880,470
|
$18,805
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-21S1
|
$61,058
|
$5,496
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-21
|
$5,994,681
|
$539,521
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
1P30CA134274-01
|
$1,463,613
|
$14,636
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNDERSTANDING TRAIL SENSITIVITY IN HUMAN GLIOMA
|
5R01CA115638-03
|
$239,527
|
$239,527
|
PIEPER, RUSS
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Ultra-HTP Multiplex Approach to Small Molecule Screens
|
1R43CA112827-01A2
|
$132,000
|
$132,000
|
MIELNICKI, LAWRENCE
|
BUFFALO MOLECULAR TARGET LABORATORY
|
|
|
Ultra-fast 15N Imaging in Choline in Cancer
|
5R01CA122513-02
|
$258,039
|
$258,039
|
ROSS, BRIAN
|
HUNTINGTON MEDICAL RESEARCH INSTITUTES
|
|
|
UCLA Cancer Education and Career Development Program
|
5R25CA087949-09
|
$507,895
|
$101,579
|
Bastani, Roshan
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Two Compartment Models to Improve Brain Tumor Therapy
|
9R01CA137488-14A1
|
$494,277
|
$494,277
|
NEUWELT, EDWARD
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
|
Tumor Sensitization to Purine Analogs by E. coli PNP
|
5R01CA119170-03
|
$332,765
|
$113,140
|
SORSCHER, Eric
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
Tumor Microenvironment Interactions in Brain Tumors
|
5U54CA126518-03
|
$1,122,151
|
$1,122,151
|
HOLLAND, ERIC
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Tumor drug delivery systems based on polymalic acid
|
5R01CA123495-03
|
$274,041
|
$137,021
|
LJUBIMOVA, JULIA
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
Tumor Cell Biology Training Program
|
5T32CA009361-28
|
$345,047
|
$120,766
|
STILES, CHARLES
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Tumor Cell Biology Training Program
|
5T32CA009056-33
|
$372,913
|
$130,520
|
FOX, CHARLES
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Tryptophan Metabolism in Human Brain Tumors
|
1R01CA123451-01A2
|
$313,772
|
$313,772
|
JUHASZ, CSABA
|
WAYNE STATE UNIVERSITY
|
|
|
TRICCS: Targeting Inattention in Childhood Cancer Survivors
|
5R03CA132570-02
|
$78,000
|
$39,000
|
Hardy, Kristina K.
|
DUKE UNIVERSITY
|
|
|
Treatment Planning using Physiologic MRI Data
|
3R01CA118365-02S1
|
$21,119
|
$21,119
|
MEYERAND, M
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
Treatment Planning using Physiologic MRI Data
|
5R01CA118365-02
|
$268,227
|
$268,227
|
MEYERAND, M
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
Treatment of Malignant Gliomas with 2-5A-anti-hTR
|
5R01CA108558-05
|
$293,510
|
$293,510
|
BOGLER, OLIVER
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Translational Applications of mda-7/IL-24 in Cancer
|
7P01CA104177-04
|
$1,329,682
|
$438,795
|
FISHER, PAUL
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Transgenic in vivo delivery of MDA7/IL24 for maligannt glioma therapy
|
1R01CA129489-01A2
|
$342,194
|
$342,194
|
GERMANO, ISABELLE
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
|
Training Program in Nervous System Tumors
|
5K12CA090354-08
|
$518,992
|
$518,992
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Training Program in Cancer Therapeutics
|
5T32CA117846-03
|
$346,294
|
$69,259
|
WALTZ, SUSAN
|
UNIVERSITY OF CINCINNATI
|
|
|
Toward a molecular classification of human gliomas
|
5R01CA057683-15
|
$298,678
|
$298,678
|
LOUIS, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Total Synthesis of Anticancer Agents Superstolides A & B
|
5R01CA109208-02
|
$270,014
|
$67,504
|
JIN, ZHENDONG
|
UNIVERSITY OF IOWA
|
|
|
Tools for Large-Scale Analysis of Driver Pathways
|
1R21CA135877-01
|
$221,400
|
$75,276
|
KARCHIN, RACHEL
|
JOHNS HOPKINS UNIVERSITY
|
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-25
|
$721,858
|
$7,219
|
SCHAEFER, PAUL
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
|
Thyroid Hormone Receptors in Health and Disease
|
Z01 BC 008752
|
$994,716
|
$149,207
|
Cheng, Sheue-yann
|
CCR (NCI)
|
|
|
Therapeutics Studies of Primary CNS Malignancies
|
5U01CA062407-14
|
$142,136
|
$140,715
|
WEN, PATRICK
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Therapeutic Studies of Primary CNS Malignancies-NABTT
|
5U01CA105706-05
|
$70,948
|
$70,948
|
BARNETT, GENE
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
Therapeutic Studies of Anaplastic Gliomas
|
5U01CA076607-10
|
$119,037
|
$119,037
|
NABORS, LOUIS
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
Therapeutic modulation of angiogenesis in human gliomas
|
5R01CA086335-07
|
$318,638
|
$318,638
|
VAN MEIR, ERWIN
|
EMORY UNIVERSITY
|
|
|
Therapeutic approaches that target cancer cell metabolism
|
1K23CA120862-01A2
|
$137,295
|
$41,189
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
The Ureb-1 ubiquitin ligase in neural stem cells and cancer
|
1R01CA131126-01A1
|
$332,623
|
$332,623
|
LASORELLA, ANNA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Total relevant funding to Neurosciences Research for this search: $159,910,680
|
